Design Therapeutics DSGN
NASDAQ DSGN
$10.73 -0.37 (-3.33%)
At close: Oct 21, 2026 · 4:00 PM EDT

Design Therapeutics (DSGN) Other Non-Current Liabilities (2020 - 2021)

Updated

Design Therapeutics (DSGN) reported Other Non-Current Liabilities of $11,000 for Q3 2021, down 92.1% from the prior quarter.

Analysis

Design Therapeutics (DSGN) Other Non-Current Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Design Therapeutics posted Other Non-Current Liabilities of $145,000.

  • Per Business Quant data, the three quarters before Q3 2021 came in at $140,000 (Q2 2021), $142,000 (Q1 2021) and $145,000 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Design Therapeutics 669.43 Mn -186.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 11,000.00
Jun 30, 2021 140,000.00
Mar 31, 2021 142,000.00
Dec 31, 2020 145,000.00
API Access

Design Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=DSGN&period=max&api_key=YOUR_API_KEY